liver. 6 Ueda et al have recently reported that Japanese patients with IPF are more likely to Background -Previous studies have shown that patients with idiopathic pul-be seropositive for HCV than normal controls, suggesting that HCV infection may play a part monary fibrosis (IPF) were more likely to be seropositive for hepatitis C virus (HCV) in the pathogenesis of IPF.
Values are median (ranges). S=smoker; ES=ex-smoker; NS=non-smoker; VC=vital capacity; FEV 1 =forced expiratory volume in one second; T=carbon monoxide transfer factor.
if they had quit smoking more than six months segmental bronchus and 150 ml of sterile normal saline (37°C) was infused in boluses of earlier, or non-smokers (NS) if they had never smoked. More information on the subjects is 50 ml. 16 17 The fluid was aspirated under low suction immediately after each instillation and shown in table 1 .
A diagnosis of chronic hepatitis C required filtered through gauze. One small aliquot of this fluid was used to count total cell numbers. a history of liver dysfunction of six months or longer with abnormal serum levels of glutamine Another aliquot was spun in a cytometer (500 rpm for five minutes) and stained with oxaloacetic transaminase (sGOT) and glutamic pyruvic transaminase (sGPT), positive serum May-Grunwald-Giemsa to identify cell populations. Five hundred cells, excluding epithelial HCV antibody determined with a second generation enzyme-linked immunosorbent assay cells, were used per count (×100, oil objective). Neutrophil, eosinophil, granulocyte, (ELISA) kit (Immucheck-HCV Ab, Kokusai, Kobe, Japan), and biopsy evidence of chronic lymphocyte, and alveolar macrophage numbers were expressed both as a percentage of a 500-inflammation of the liver without evidence of cirrhosis. The histological findings for the liver cell aliquot and as the actual lavage fluid concentration. The remaining BAL fluid was centin the pretreatment group included chronic persistent hepatitis (CPH) in five patients, rifuged at 300 g for 10 minutes at 4°C and the supernatant removed. The BAL fluid pellet chronic active hepatitis 2A (CAH2A) in four, and CAH2B in four. The post-treatment group was analysed for lymphocyte subsets by flow cytometry using CD2, CD3, CD4, CD8, included four patients with CPH, two with CAH2A, and four with CAH2B. Three patients CD20 and HLA-Dr monoclonal antibodies (Becton Dickinson Co, Mountain View, Caliin the pretreatment group did not agree to undergo a second bronchoscopy. Those who fornia, USA). The supernatant was concentrated 100 times using an Amicon (Div. had received a Shosaikoto (a Chinese medicine) during the previous six months were excluded. WR Grace & Co, Danvers, Massachusetts, USA) and IL-1 , TNF-, and HGF were measIn Japan an increased frequency of interstitial pneumonitis has been observed following treat-ured in duplicate using radioimmunoassay kits. ment with Shosaikoto for chronic hepatitis C (unpublished data).
The study was performed according to the   Values in the text, tables and figures are excriteria set out in the Helsinki Declaration, and free and informed consent was obtained from pressed as medians and ranges. The MannWhitney non-parametric test was used for comall subjects.
parison between the groups and the KruskalWallis test was used for comparison of the medians of all three groups. A p value of less    Spirometric tests were performed with a water than 0.05 was considered significant. spirometer (Godart Expirograph, GodartStatham, Bilthoven, Holland) and the vital capacity (VC) and percentage of forced vital Results    -capacity expired in one second (FEV 1 /FVC) were calculated. The carbon monoxide transfer In the pretreatment group sGOT and sGPT levels were 54-377 U/l (median 145 U/l) and factor (T) was measured by the single breath method 15 (Pulmocorder Model R1551S, 102-487 U/l (median 160 U/l), respectively. After treatment the levels of sGOT and sGPT Anima, Tokyo, Japan). VC and T were expressed as percentage predicted.
were both significantly lower (p<0.01) at 20-168 U/l (median 58 U/l) and 12-176 U/l (median 81 U/l), respectively.    14 15 Bronchoscopy was performed once in normal subjects before treatment and 2-8 (median 3)   
The pulmonary function test parameters were weeks after treatment with IFN-in the patients with HCV.
within normal limits in all patients and controls (table 1) and pulmonary function was not Before bronchoscopy the subjects were given atropine (0.5 mg), usually combined with affected by treatment with IFN-. pethidine hydrochloride (0.5 mg/kg) subcutaneously. The upper respiratory tract was anaesthetised with 2% lignocaine. A fibreoptic      Cell concentrations in the BAL fluid from norbronchoscope (Olympus BF1T, Olympus Co, Tokyo, Japan) was wedged in the middle lobe mal subjects and from patients before and after group.bmj.com on June 16, 2017 -Published by http://thorax.bmj.com/ Downloaded from , and 27 (4-52), respectively. CD2, CD3, CD4, Lymphocyte and eosinophil counts were significantly higher in both groups compared with CD8, HLA-Dr and CD4/8 were significantly different between the three groups. In the prethe normal volunteers. treatment group an increase was seen in T lymphocytes (CD2, 78-98%; CD3, 54-94%) and in the CD4 helper subset (67 (23-81)%).
    
The results of surface marker analysis of lym-The number of lymphocytes with HLA-Dr (range 40-74%), a marker of early T cell acphocytes are outlined in fig 1. In the normal controls the percentage medians and ranges of tivation, was significantly higher than in the normal controls. However, the CD4/CD8 ratio CD2, CD3, CD4, CD8 and HLA-Dr were 67 group.bmj.com on June 16, 2017 -Published by http://thorax.bmj.com/ Downloaded from (range 0.09-1.15) was almost the same as that Bronchoalveolar lavage is a useful method in the controls. The number of B lymphocytes for investigating both the pathogenesis and (CD20, median and range 1 (0-6)%) was not the diagnosis and management of pulmonary increased. On the other hand, after treatment diseases, particularly interstitial lung the levels of CD2 (4-98%), CD3 (4-75%), diseases. 4 16 17 20 The percentage of lymphocytes and CD4 (32 (3-82)%) subsets were normal. is increased in sarcoidosis and hypersensitivity The CD8 subset (6 (0-16)) was significantly pneumonitis, under which conditions lymphodecreased and the CD4/CD8 ratio (2.2-30) cytic alveolitis is exhibited. Laviolette 21 and was significantly increased compared with the Merchant et al 22 determined the distribution of normal controls. cells in the BAL fluid of normal subjects and reported that a concentration of lymphocytes above 14% should be considered abnormal. According to this criterion, the patients in both      groups in the present study showed a significant The IL-1 , TNF-, and HGF levels were all increase in the percentage of lymphocytes in the less than the lower limits for detection. The BAL fluid. We did not perform lung biopsies so albumin levels in the BAL fluid did not differ the histological presence of pneumonitis was significantly between the three groups.
not determined, but we speculate that HCV infection has the potential to induce lymphocytic alveolitis and fibrotic changes in the lung.
Discussion
It seems likely that the increase in HLA-Dr+ In this study we have analysed the BAL fluid lymphocytes in the pretreatment group was in patients with chronic hepatitis C before and activated by HCV and that the antiviral activity after treatment with IFN-to investigate the effects of the administration of IFN-can possibility that HCV infection and/or IFNdecrease the percentage of HLA-Dr+ treatment are involved in the pathogenesis of lymphocytes. 23 24 pulmonary fibrosis or alveolitis.
In the pretreatment group the high count Patients with chronic hepatitis C had sig-of eosinophils in the BAL fluid may be of nificantly increased concentrations of lym-importance in the pathogenesis of the disease. 10 phocytes, eosinophils and neutrophils in their After treatment with IFN-the eosinophil BAL fluid, although the total cell counts did count was similar to that before treatment. not differ from those in the normal volunteers. 10 Eosinophils have a potent armamentarium of The lymphocytes were identified as T cells highly cytotoxic products that may be involved (CD2+ and CD3+) and the T helper/inducer in the development of tissue damage. [25] [26] [27] It has subset of cells (CD4+). The number of lym-recently been suggested that the eosinophilia phocytes expressing HLA-Dr (the expression in the BAL fluid may, in fact, be a marker of of class II major histocompatibility complex progressive lung disease in patients with IPF. 28 antigens on T lymphocytes), a marker of early The increase in the eosinophil count in the T cell activation, was also increased. The num-BAL fluid seen in this study, although lower bers of T suppressor/cytotoxic cells (CD8+) than in the IPF study, may nonetheless suggest and B lymphocytes (CD20+) were not in-a role for eosinophils in the development of creased. The CD4/CD8 ratio was almost the alveolitis and/or pulmonary fibrosis. IFN-did same as that in the normal volunteers. The not affect the level of eosinophils in the BAL CD4/CD8 ratio (3.75 (0.89)) found in our fluid. normal controls is higher than the control val-
The part played by IFN-in the pathogenesis ues of 1.4-2.7 reported in other laboratories. 18 of IPF is unknown. Pneumonitis associated There is no clear explanation for this, which is with IFN-has been reported in case reports a consistent finding in studies in our unit. In on the treatment of malignant diseases with our unit the CD4/CD8 ratio in patients with anticancer drugs 29 and recently in the treatment sarcoidosis is higher (6.8 (1.2) ).
of chronic hepatitis C. [11] [12] [13] [14] In general, drug The levels of IL-1 , TNF-, and HGF were induced pneumonitis can be kept under control all less than the detection limit. This is in by stopping the drug treatment and/or adcontrast with studies in progressive IPF and ministering corticosteroids. However, pneuadult/acute respiratory distress syndrome monitis associated with IFN-treatment may (ARDS) in which increased levels of IL-1 , have several forms such as an allergic reaction TNF-, and HGF were reported in the BAL or cytotoxicity, and the conditions associated fluid. 19 with treatment are not always reversible when We believe that smoking had little effect on the drug therapy is discontinued, as has been the cell populations in the BAL fluid since the reported for IFN-neurotoxicity. 30 number of current smokers was similar in both In summary, we have demonstrated siggroups and the cell population profiles of exnificantly increased levels of lymphocytes, smokers were almost identical to those of nonmainly active T cells, and eosinophils in the smokers.
18
BAL fluid of patients with chronic hepatitis C, On the other hand, after treatment the conand have found evidence that IFN-treatment centrations of lymphocytes and eosinophils appears to alter lymphocyte surface markers. were similar to those before treatment although HCV infection might be a trigger of lymphoalmost all lymphocyte surface marker values cytic alveolitis. Treatment with IFN-appears were similar to those in the normal volunteers to be beneficial for chronic hepatitis C and has and, surprisingly, the HLA-Dr value was within the normal range.
no adverse effects on pulmonary abnormalities.
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